![YJG YJG](https://data.pdbj.org/pdbjplus/data/cc/svg/YJG.svg) | YJG | Name: | 2-(5-chloro-6-oxopyridazin-1(6H)-yl)-N-(4-methyl-3-{[2-(pyridin-2-yl)ethyl]sulfamoyl}phenyl)acetamide | Formula: | C20 H20 Cl N5 O4 S | SMILES: | O=C(CN1N=CC=C(Cl)C1=O)Nc1ccc(C)c(c1)S(=O)(=O)NCCc1ccccn1 | InChi: | InChI=1S/C20H20ClN5O4S/c1-14-5-6-16(25-19(27)13-26-20(28)17(21)8-10-23-26)12-18(14)31(29,30)24-11-7-15-4-2-3-9-22-15/h2-6,8-10,12,24H,7,11,13H2,1H3,(H,25,27) | Definition date: | 2021-03-10 | Last modified: | 2021-03-12 | Release date: | 2021-03-17 | Identifier: | 2-(5-chloro-6-oxopyridazin-1(6H)-yl)-N-(4-methyl-3-{[2-(pyridin-2-yl)ethyl]sulfamoyl}phenyl)acetamide |
|
![Y2P Y2P](https://data.pdbj.org/pdbjplus/data/cc/svg/Y2P.svg) | Y2P | Name: | 2-[4-[(3'R,4S)-3'-fluoro-1-[2-[(4-fluorophenyl)methyl-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]amino]-2-oxo-ethyl]-2,5-dioxo-spiro[imidazolidine-4,1'-indane]-5'-yl]pyrazol-1-yl]-N-methyl-acetamide | Formula: | C29 H27 F5 N6 O4 | SMILES: | N4(C(C1(CC(c2c1ccc(c2)c3cn(nc3)CC(=O)NC)F)NC4=O)=O)CC(N(Cc5ccc(cc5)F)C(C)C(F)(F)F)=O | InChi: | InChI=1S/C29H27F5N6O4/c1-16(29(32,33)34)39(12-17-3-6-20(30)7-4-17)25(42)15-40-26(43)28(37-27(40)44)10-23(31)21-9-18(5-8-22(21)28)19-11-36-38(13-19)14-24(41)35-2/h3-9,11,13,16,23H,10,12,14-15H2,1-2H3,(H,35,41)(H,37,44)/t16-,23+,28-/m0/s1 | Definition date: | 2021-01-29 | Last modified: | 2021-03-12 | Release date: | 2021-03-17 | Identifier: | 2-[(3'R,4S)-3'-fluoro-5'-{1-[2-(methylamino)-2-oxoethyl]-1H-pyrazol-4-yl}-2,5-dioxo-2',3'-dihydro-1H-spiro[imidazolidine-4,1'-inden]-1-yl]-N-[(4-fluorophenyl)methyl]-N-[(2S)-1,1,1-trifluoropropan-2-yl]acetamide |
|
![XN7 XN7](https://data.pdbj.org/pdbjplus/data/cc/svg/XN7.svg) | XN7 | Name: | N,N~2~-bis(2-hydroxyethyl)glycinamide | Formula: | C6 H14 N2 O3 | SMILES: | C(CNCC(NCCO)=O)O | InChi: | InChI=1S/C6H14N2O3/c9-3-1-7-5-6(11)8-2-4-10/h7,9-10H,1-5H2,(H,8,11) | Definition date: | 2020-12-22 | Last modified: | 2021-03-12 | Release date: | 2021-03-17 | Identifier: | N,N~2~-bis(2-hydroxyethyl)glycinamide |
|
![SWJ SWJ](https://data.pdbj.org/pdbjplus/data/cc/svg/SWJ.svg) | SWJ | Name: | 2-azanyl-~{N}-[(3~{S})-2-oxidanylidenehex-5-yn-3-yl]ethanamide | Formula: | C8 H12 N2 O2 | SMILES: | CC(=O)[CH](CC#C)NC(=O)CN | InChi: | InChI=1S/C8H12N2O2/c1-3-4-7(6(2)11)10-8(12)5-9/h1,7H,4-5,9H2,2H3,(H,10,12)/t7-/m0/s1 | Definition date: | 2020-03-12 | Last modified: | 2021-03-12 | Release date: | 2021-03-17 | Identifier: | 2-azanyl-~{N}-[(3~{S})-2-oxidanylidenehex-5-yn-3-yl]ethanamide |
|
![U72 U72](https://data.pdbj.org/pdbjplus/data/cc/svg/U72.svg) | U72 | Name: | 2-methyl-1,2,6,7-tetrahydro-3H,5H-pyrido[3,2,1-ij]quinazolin-3-imine | Formula: | C12 H15 N3 | SMILES: | CN1Cc2cccc3CCCN(C1=N)c23 | InChi: | InChI=1S/C12H15N3/c1-14-8-10-5-2-4-9-6-3-7-15(11(9)10)12(14)13/h2,4-5,13H,3,6-8H2,1H3/b13-12+ | Synonyms: | 3-methyl-1,3-diazatricyclo[7.3.1.0^{5,13}]trideca-5,7,9(13)-trien-2-imine | Definition date: | 2021-01-27 | Last modified: | 2021-03-12 | Release date: | 2021-03-17 | Identifier: | 3-methyl-1,3-diazatricyclo[7.3.1.0^{5,13}]trideca-5,7,9(13)-trien-2-imine |
|
![U7H U7H](https://data.pdbj.org/pdbjplus/data/cc/svg/U7H.svg) | U7H | Name: | 2-hydroxy-1-(4-(isoquinolin-5-yl)piperazin-1-yl)-2-methyl-3-(3-methyl-4-phenyl-1H-pyrazol-1-yl)propan-1-one | Formula: | C27 H29 N5 O2 | SMILES: | Cc1nn(C[C](C)(O)C(=O)N2CCN(CC2)c3cccc4cnccc34)cc1c5ccccc5 | InChi: | InChI=1S/C27H29N5O2/c1-20-24(21-7-4-3-5-8-21)18-32(29-20)19-27(2,34)26(33)31-15-13-30(14-16-31)25-10-6-9-22-17-28-12-11-23(22)25/h3-12,17-18,34H,13-16,19H2,1-2H3/t27-/m0/s1 | Synonyms: | (2~{S})-1-(4-isoquinolin-5-ylpiperazin-1-yl)-2-methyl-3-(3-methyl-4-phenyl-pyrazol-1-yl)-2-oxidanyl-propan-1-one | Definition date: | 2021-01-28 | Last modified: | 2021-03-12 | Release date: | 2021-03-17 | Identifier: | (2~{S})-1-(4-isoquinolin-5-ylpiperazin-1-yl)-2-methyl-3-(3-methyl-4-phenyl-pyrazol-1-yl)-2-oxidanyl-propan-1-one |
|
![U7K U7K](https://data.pdbj.org/pdbjplus/data/cc/svg/U7K.svg) | U7K | Name: | (E)-3-((5,6-dihydro-2H,4H-thiazolo[5,4,3-ij]quinolin-2-ylidene)amino)-2-hydroxy-1-(4-(isoquinolin-5-yl)piperazin-1-yl)-2-methylpropan-1-one | Formula: | C27 H29 N5 O2 S | SMILES: | C[C](O)(CN=C1Sc2cccc3CCCN1c23)C(=O)N4CCN(CC4)c5cccc6cnccc56 | InChi: | InChI=1S/C27H29N5O2S/c1-27(34,18-29-26-32-12-4-7-19-5-3-9-23(35-26)24(19)32)25(33)31-15-13-30(14-16-31)22-8-2-6-20-17-28-11-10-21(20)22/h2-3,5-6,8-11,17,34H,4,7,12-16,18H2,1H3/b29-26+/t27-/m0/s1 | Synonyms: | (2~{S})-1-(4-isoquinolin-5-ylpiperazin-1-yl)-2-methyl-2-oxidanyl-3-[(~{E})-3-thia-1-azatricyclo[6.3.1.0^{4,12}]dodeca-4(12),5,7-trien-2-ylideneamino]propan-1-one | Definition date: | 2021-01-28 | Last modified: | 2021-03-12 | Release date: | 2021-03-17 | Identifier: | (2~{S})-1-(4-isoquinolin-5-ylpiperazin-1-yl)-2-methyl-2-oxidanyl-3-[(~{E})-3-thia-1-azatricyclo[6.3.1.0^{4,12}]dodeca-4(12),5,7-trien-2-ylideneamino]propan-1-one |
|
![SZD SZD](https://data.pdbj.org/pdbjplus/data/cc/svg/SZD.svg) | SZD | Name: | 3,5-bis(fluoranyl)-~{N}-[3-[[4-(trifluoromethyloxy)phenyl]sulfamoyl]phenyl]benzamide | Formula: | C20 H13 F5 N2 O4 S | SMILES: | Fc1cc(F)cc(c1)C(=O)Nc2cccc(c2)[S](=O)(=O)Nc3ccc(OC(F)(F)F)cc3 | InChi: | InChI=1S/C20H13F5N2O4S/c21-13-8-12(9-14(22)10-13)19(28)26-16-2-1-3-18(11-16)32(29,30)27-15-4-6-17(7-5-15)31-20(23,24)25/h1-11,27H,(H,26,28) | Definition date: | 2020-03-13 | Last modified: | 2021-03-12 | Release date: | 2021-03-17 | Identifier: | 3,5-bis(fluoranyl)-~{N}-[3-[[4-(trifluoromethyloxy)phenyl]sulfamoyl]phenyl]benzamide |
|
![S5W S5W](https://data.pdbj.org/pdbjplus/data/cc/svg/S5W.svg) | S5W | Name: | Macrocyclic SAFit analogue 55 | Formula: | C41 H51 N O9 | SMILES: | COc1ccc(CC[CH]2OC(=O)[CH]3CCCCN3C(=O)[CH](C4CCCCC4)c5cc(OC)c(OCCOc6cccc2c6)c(OC)c5)cc1OC | InChi: | InChI=1S/C41H51NO9/c1-45-34-19-17-27(23-35(34)46-2)16-18-33-29-13-10-14-31(24-29)49-21-22-50-39-36(47-3)25-30(26-37(39)48-4)38(28-11-6-5-7-12-28)40(43)42-20-9-8-15-32(42)41(44)51-33/h10,13-14,17,19,23-26,28,32-33,38H,5-9,11-12,15-16,18,20-22H2,1-4H3/t32-,33+,38-/m0/s1 | Definition date: | 2020-11-10 | Last modified: | 2021-03-12 | Release date: | 2021-03-17 |
|
![SZV SZV](https://data.pdbj.org/pdbjplus/data/cc/svg/SZV.svg) | SZV | Name: | 4-{[2-(2-hydroxyphenyl)imidazo[1,2-a]pyrazin-3-yl]amino}benzene-1,2-dicarboxylic acid | Formula: | C20 H14 N4 O5 | SMILES: | c2(c(n1c(cncc1)n2)Nc3ccc(c(C(O)=O)c3)C(O)=O)c4c(cccc4)O | InChi: | InChI=1S/C20H14N4O5/c25-15-4-2-1-3-13(15)17-18(24-8-7-21-10-16(24)23-17)22-11-5-6-12(19(26)27)14(9-11)20(28)29/h1-10,22,25H,(H,26,27)(H,28,29) | Definition date: | 2020-03-16 | Last modified: | 2021-03-12 | Release date: | 2021-03-17 | Identifier: | 4-{[2-(2-hydroxyphenyl)imidazo[1,2-a]pyrazin-3-yl]amino}benzene-1,2-dicarboxylic acid |
|
![WCY WCY](https://data.pdbj.org/pdbjplus/data/cc/svg/WCY.svg) | WCY | Name: | N-{4-[({(1S)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl}carbamothioyl)amino]phenyl}-1,3-thiazole-4-carboxamide | Formula: | C21 H16 F6 N4 O S2 | SMILES: | c3nc(C(Nc2ccc(NC(=S)NC(C)c1cc(cc(C(F)(F)F)c1)C(F)(F)F)cc2)=O)cs3 | InChi: | InChI=1S/C21H16F6N4OS2/c1-11(12-6-13(20(22,23)24)8-14(7-12)21(25,26)27)29-19(33)31-16-4-2-15(3-5-16)30-18(32)17-9-34-10-28-17/h2-11H,1H3,(H,30,32)(H2,29,31,33)/t11-/m0/s1 | Definition date: | 2020-10-14 | Last modified: | 2021-03-12 | Release date: | 2021-03-17 | Identifier: | N-{4-[({(1S)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl}carbamothioyl)amino]phenyl}-1,3-thiazole-4-carboxamide |
|
![Q1W Q1W](https://data.pdbj.org/pdbjplus/data/cc/svg/Q1W.svg) | Q1W | Name: | 2,2-dimethyl-4-oxidanylidene-pentanedioic acid | Formula: | C7 H10 O5 | SMILES: | CC(C)(CC(=O)C(O)=O)C(O)=O | InChi: | InChI=1S/C7H10O5/c1-7(2,6(11)12)3-4(8)5(9)10/h3H2,1-2H3,(H,9,10)(H,11,12) | Definition date: | 2020-05-06 | Last modified: | 2021-03-12 | Release date: | 2021-03-17 | Identifier: | 2,2-dimethyl-4-oxidanylidene-pentanedioic acid |
|
![Q1Z Q1Z](https://data.pdbj.org/pdbjplus/data/cc/svg/Q1Z.svg) | Q1Z | Name: | (3~{R})-3-methyl-2-oxidanylidene-pentanedioic acid | Formula: | C6 H8 O5 | SMILES: | C[CH](CC(O)=O)C(=O)C(O)=O | InChi: | InChI=1S/C6H8O5/c1-3(2-4(7)8)5(9)6(10)11/h3H,2H2,1H3,(H,7,8)(H,10,11)/t3-/m1/s1 | Definition date: | 2020-05-06 | Last modified: | 2021-03-12 | Release date: | 2021-03-17 | Identifier: | (3~{R})-3-methyl-2-oxidanylidene-pentanedioic acid |
|
![Q7G Q7G](https://data.pdbj.org/pdbjplus/data/cc/svg/Q7G.svg) | Q7G | Name: | 2-{[(4-O-alpha-D-glucopyranosyl-alpha-D-glucopyranosyl)oxy]methyl}-4-{[(3beta,9beta,14beta,17beta,25R)-spirost-5-en-3-yl]oxy}butyl 4-O-alpha-D-glucopyranosyl-alpha-D-glucopyranoside | Formula: | C56 H92 O25 | SMILES: | C6=1C(C5C(CC=1)C4CC3C(C(C2(CCC(CO2)C)O3)C)C4(C)CC5)(CCC(C6)OCCC(COC7C(O)C(O)C(C(O7)CO)OC8C(C(O)C(C(O8)CO)O)O)COC9OC(C(C(C9O)O)OC%10C(C(C(O)C(CO)O%10)O)O)CO)C | InChi: | InChI=1S/C56H92O25/c1-24-7-13-56(74-21-24)25(2)37-32(81-56)16-31-29-6-5-27-15-28(8-11-54(27,3)30(29)9-12-55(31,37)4)71-14-10-26(22-72-50-46(69)42(65)48(35(19-59)77-50)79-52-44(67)40(63)38(61)33(17-57)75-52)23-73-51-47(70)43(66)49(36(20-60)78-51)80-53-45(68)41(64)39(62)34(18-58)76-53/h5,24-26,28-53,57-70H,6-23H2,1-4H3/t24-,25+,28+,29-,30+,31+,32+,33-,34-,35-,36-,37+,38-,39-,40+,41+,42-,43-,44-,45-,46-,47-,48-,49-,50+,51+,52-,53-,54+,55+,56-/m1/s1 | Definition date: | 2019-09-30 | Last modified: | 2021-03-12 | Release date: | 2021-03-17 | Identifier: | 2-{[(4-O-alpha-D-glucopyranosyl-alpha-D-glucopyranosyl)oxy]methyl}-4-{[(3beta,9beta,14beta,17beta,25R)-spirost-5-en-3-yl]oxy}butyl 4-O-alpha-D-glucopyranosyl-alpha-D-glucopyranoside |
|
![QA8 QA8](https://data.pdbj.org/pdbjplus/data/cc/svg/QA8.svg) | QA8 | Name: | (3~{R})-3-ethyl-2-oxidanylidene-pentanedioic acid | Formula: | C7 H10 O5 | SMILES: | CC[CH](CC(O)=O)C(=O)C(O)=O | InChi: | InChI=1S/C7H10O5/c1-2-4(3-5(8)9)6(10)7(11)12/h4H,2-3H2,1H3,(H,8,9)(H,11,12)/t4-/m1/s1 | Definition date: | 2020-05-29 | Last modified: | 2021-03-12 | Release date: | 2021-03-17 | Identifier: | (3~{R})-3-ethyl-2-oxidanylidene-pentanedioic acid |
|
![QET QET](https://data.pdbj.org/pdbjplus/data/cc/svg/QET.svg) | QET | Name: | [5-fluoranyl-6-(oxan-4-yloxy)-1,3-dihydroisoindol-2-yl]-[5-methylsulfonyl-2-[2,2,3,3,3-pentakis(fluoranyl)propoxy]phenyl]methanone | Formula: | C24 H23 F6 N O6 S | SMILES: | C[S](=O)(=O)c1ccc(OCC(F)(F)C(F)(F)F)c(c1)C(=O)N2Cc3cc(F)c(OC4CCOCC4)cc3C2 | InChi: | InChI=1S/C24H23F6NO6S/c1-38(33,34)17-2-3-20(36-13-23(26,27)24(28,29)30)18(10-17)22(32)31-11-14-8-19(25)21(9-15(14)12-31)37-16-4-6-35-7-5-16/h2-3,8-10,16H,4-7,11-13H2,1H3 | Definition date: | 2020-06-10 | Last modified: | 2021-03-12 | Release date: | 2021-03-17 | Identifier: | [5-fluoranyl-6-(oxan-4-yloxy)-1,3-dihydroisoindol-2-yl]-[5-methylsulfonyl-2-[2,2,3,3,3-pentakis(fluoranyl)propoxy]phenyl]methanone |
|
![G72 G72](https://data.pdbj.org/pdbjplus/data/cc/svg/G72.svg) | G72 | Name: | (1R,3R,7E,17beta)-17-[(1S)-6,6,6-trifluoro-5-hydroxy-1-(4-hydroxy-4-methylpentyl)-5-(trifluoromethyl)hex-3-yn-1-yl]-9,10-secoestra-5,7-diene-1,3-diol | Formula: | C31 H44 F6 O4 | SMILES: | FC(F)(F)C(O)(C#CCC(CCCC(O)(C)C)C2CCC3C(=CC=C1CC(O)CC(O)C1)CCCC23C)C(F)(F)F | InChi: | InChI=1S/C31H44F6O4/c1-27(2,40)14-4-7-21(9-6-16-29(41,30(32,33)34)31(35,36)37)25-12-13-26-22(8-5-15-28(25,26)3)11-10-20-17-23(38)19-24(39)18-20/h10-11,21,23-26,38-41H,4-5,7-9,12-15,17-19H2,1-3H3/b22-11+/t21-,23+,24+,25+,26-,28+/m0/s1 | Synonyms: | 1,25-dihydroxy-20S-21(3-trideuteromethyl-3-hydroxy-4,4,4-trideuterobutyl)-23-yne-26,27-hexafluoro-19-nor-cholecalciferol | Definition date: | 2010-07-22 | Last modified: | 2021-03-12 | Identifier: | (1R,3R,7E,17beta)-17-[(6S)-1,1,1-trifluoro-2,10-dihydroxy-10-methyl-2-(trifluoromethyl)undec-3-yn-6-yl]-9,10-secoestra-5,7-diene-1,3-diol |
|
![HZF HZF](https://data.pdbj.org/pdbjplus/data/cc/svg/HZF.svg) | HZF | Name: | (3R,4R,5S)-4-acetamido-3-pentan-3-yloxy-5-(4-phenyl-1,2,3-triazol-1-yl)cyclohexene-1-carboxylic acid | Formula: | C22 H28 N4 O4 | SMILES: | CCC(CC)O[CH]1C=C(C[CH]([CH]1NC(C)=O)n2cc(nn2)c3ccccc3)C(O)=O | InChi: | InChI=1S/C22H28N4O4/c1-4-17(5-2)30-20-12-16(22(28)29)11-19(21(20)23-14(3)27)26-13-18(24-25-26)15-9-7-6-8-10-15/h6-10,12-13,17,19-21H,4-5,11H2,1-3H3,(H,23,27)(H,28,29)/t19-,20+,21+/m0/s1 | Definition date: | 2021-03-02 | Last modified: | 2021-03-12 | Release date: | 2021-03-17 | Identifier: | (3~{R},4~{R},5~{S})-4-acetamido-3-pentan-3-yloxy-5-(4-phenyl-1,2,3-triazol-1-yl)cyclohexene-1-carboxylic acid |
|
![GZF GZF](https://data.pdbj.org/pdbjplus/data/cc/svg/GZF.svg) | GZF | Name: | [(2R,3R,4S,5S)-5-(2-azanyl-6-oxidanyl-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl bis(oxidanyl)phosphinothioyl hydrogen phosphate | Formula: | C10 H15 N5 O10 P2 S | SMILES: | Nc1nc(O)c2ncn([CH]3O[CH](CO[P](O)(=O)O[P](O)(O)=S)[CH](O)[CH]3O)c2n1 | InChi: | InChI=1S/C10H15N5O10P2S/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(24-9)1-23-26(19,20)25-27(21,22)28/h2-3,5-6,9,16-17H,1H2,(H,19,20)(H2,21,22,28)(H3,11,13,14,18)/t3-,5+,6+,9+/m1/s1 | Definition date: | 2020-10-12 | Last modified: | 2021-03-12 | Release date: | 2021-03-17 | Identifier: | [(2~{R},3~{R},4~{S},5~{S})-5-(2-azanyl-6-oxidanyl-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl bis(oxidanyl)phosphinothioyl hydrogen phosphate |
|
![2RP 2RP](https://data.pdbj.org/pdbjplus/data/cc/svg/2RP.svg) | 2RP | Name: | (2R)-pentan-2-ol | Formula: | C5 H12 O | SMILES: | OC(C)CCC | InChi: | InChI=1S/C5H12O/c1-3-4-5(2)6/h5-6H,3-4H2,1-2H3/t5-/m1/s1 | Definition date: | 2008-04-10 | Last modified: | 2021-03-12 | Release date: | 2021-03-17 | Identifier: | (2R)-pentan-2-ol |
|
![FWL FWL](https://data.pdbj.org/pdbjplus/data/cc/svg/FWL.svg) | FWL | Name: | 3-[5-(aminomethyl)-4-(carboxymethyl)-2-iodo-1H-pyrrol-3-yl]propanoic acid | Formula: | C10 H13 I N2 O4 | SMILES: | NCc1[nH]c(I)c(CCC(O)=O)c1CC(O)=O | InChi: | InChI=1S/C10H13IN2O4/c11-10-5(1-2-8(14)15)6(3-9(16)17)7(4-12)13-10/h13H,1-4,12H2,(H,14,15)(H,16,17) | Synonyms: | 2-iodoporphobilinogen | Definition date: | 2020-06-25 | Last modified: | 2021-03-12 | Release date: | 2021-03-17 | Identifier: | 3-[5-(aminomethyl)-4-(2-hydroxy-2-oxoethyl)-2-iodanyl-1~{H}-pyrrol-3-yl]propanoic acid |
|
![FX0 FX0](https://data.pdbj.org/pdbjplus/data/cc/svg/FX0.svg) | FX0 | Name: | (2S,4R)-4-[(3R,5S,6R,7R,8R,9S,10S,12S,13R,14S,17R)-6-ethyl-10,13-dimethyl-3,7,12-tris(oxidanyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-pentanoic acid | Formula: | C27 H46 O5 | SMILES: | CC[CH]1[CH](O)[CH]2[CH]3CC[CH]([CH](C)C[CH](C)C(O)=O)[C]3(C)[CH](O)C[CH]2[C]4(C)CC[CH](O)C[CH]14 | InChi: | InChI=1S/C27H46O5/c1-6-17-20-12-16(28)9-10-26(20,4)21-13-22(29)27(5)18(14(2)11-15(3)25(31)32)7-8-19(27)23(21)24(17)30/h14-24,28-30H,6-13H2,1-5H3,(H,31,32)/t14-,15+,16-,17-,18-,19+,20+,21+,22+,23+,24-,26+,27-/m1/s1 | Definition date: | 2020-06-30 | Last modified: | 2021-03-12 | Release date: | 2020-09-09 | Identifier: | (2~{S},4~{R})-4-[(3~{R},5~{S},6~{R},7~{R},8~{R},9~{S},10~{S},12~{S},13~{R},14~{S},17~{R})-6-ethyl-10,13-dimethyl-3,7,12-tris(oxidanyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1~{H}-cyclopenta[a]phenanthren-17-yl]-2-methyl-pentanoic acid |
|
![3EW 3EW](https://data.pdbj.org/pdbjplus/data/cc/svg/3EW.svg) | 3EW | Name: | 5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide | Formula: | C17 H15 Br Cl F N4 O3 | SMILES: | Brc1ccc(c(Cl)c1)Nc2c(F)c3ncn(c3cc2C(=O)NOCCO)C | InChi: | InChI=1S/C17H15BrClFN4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26) | Definition date: | 2014-08-04 | Last modified: | 2021-03-12 | Release date: | 2014-09-24 | Identifier: | 5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide |
|
![EUI EUI](https://data.pdbj.org/pdbjplus/data/cc/svg/EUI.svg) | EUI | Name: | [3,4-BIS(FLUORANYL)-2-[(2-FLUORANYL-4-IODANYL-PHENYL)AMINO]PHENYL]-[3-OXIDANYL-3-[(2S)-PIPERIDIN-2-YL]AZETIDIN-1-YL]METHANONE | Formula: | C21 H21 F3 I N3 O2 | SMILES: | O=C(c2ccc(F)c(F)c2Nc1ccc(I)cc1F)N4CC(O)(C3NCCCC3)C4 | InChi: | InChI=1S/C21H21F3IN3O2/c22-14-6-5-13(19(18(14)24)27-16-7-4-12(25)9-15(16)23)20(29)28-10-21(30,11-28)17-3-1-2-8-26-17/h4-7,9,17,26-27,30H,1-3,8,10-11H2/t17-/m0/s1 | Definition date: | 2012-03-14 | Last modified: | 2021-03-12 | Release date: | 2012-12-14 | Identifier: | {3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}{3-hydroxy-3-[(2S)-piperidin-2-yl]azetidin-1-yl}methanone |
|
![VRD VRD](https://data.pdbj.org/pdbjplus/data/cc/svg/VRD.svg) | VRD | Name: | ({3-[amino(oxo)acetyl]-1-benzyl-2-ethyl-1H-indol-4-yl}oxy)acetic acid | Formula: | C21 H20 N2 O5 | SMILES: | CCc2c(C(C(=O)N)=O)c1c(cccc1n2Cc3ccccc3)OCC(=O)O | InChi: | InChI=1S/C21H20N2O5/c1-2-14-19(20(26)21(22)27)18-15(9-6-10-16(18)28-12-17(24)25)23(14)11-13-7-4-3-5-8-13/h3-10H,2,11-12H2,1H3,(H2,22,27)(H,24,25) | Synonyms: | Varespladib | Definition date: | 2019-07-25 | Last modified: | 2021-03-08 | Release date: | 2019-12-04 | Identifier: | ({3-[amino(oxo)acetyl]-1-benzyl-2-ethyl-1H-indol-4-yl}oxy)acetic acid |
|